Learn About The Law
Get help with your legal needs
FindLaw’s Learn About the Law features thousands of informational articles to help you understand your options. And if you’re ready to hire an attorney, find one in your area who can help.
Current as of January 01, 2024 | Updated by Findlaw Staff
(1) This part does not apply to:
(a) protected health information that is collected by a covered entity or business associate as those terms are defined in 45 CFR, parts 160 and 164, if separate informed consent related to the collection, use, and dissemination of genetic or neurotechnology data is obtained from the consumer, parent, guardian, or power of attorney, and the covered entity or business associate follows the policies under 30-23-104(6)(a) through (6)(d);
(b) an entity when it is engaged only in collecting, using, or analyzing genetic data or biological samples in the context of scientific or clinical research conducted with the express consent of an individual and in accordance with:
(i) the federal policy for the protection of human research subjects under 45 CFR, part 46, the good clinical practice guideline issued by the international council for harmonisation of technical requirements for pharmaceuticals for human use; or
(ii) the United States food and drug administration policy for the protection of human subjects under 21 CFR, parts 50 and 56;
(c) uses by a governmental agency; or
(d) deidentified genetic data obtained from a third party to the extent that the data is used to conduct internal, medical, or scientific research. Data must be considered deidentified if:
(i) it cannot be reasonably linked to an identifiable individual; and
(ii) the entity:
(A) takes administrative and technical measures to ensure the data cannot be associated with a particular consumer;
(B) maintains and uses data in deidentified form and does not attempt to reidentify data; and
(C) enters a legally enforceable contractual obligation that prohibits a recipient of the data from attempting to reidentify the data.
(2) Any collection, storage, use, or dissemination of genetic or neurotechnology data by a governmental agency must be performed in accordance with a specific state law or executed through a search warrant or investigative subpoena issued pursuant to 46-4-301.
Cite this article: FindLaw.com - Montana Title 30. Trade and Commerce § 30-23-103. Exceptions - last updated January 01, 2024 | https://codes.findlaw.com/mt/title-30-trade-and-commerce/mt-code-ann-sect-30-23-103/
FindLaw Codes may not reflect the most recent version of the law in your jurisdiction. Please verify the status of the code you are researching with the state legislature before relying on it for your legal needs.
A free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes, visit FindLaw’s Learn About the Law.
Make It a Preferred Google Search Source
Add to GoogleGet help with your legal needs
FindLaw’s Learn About the Law features thousands of informational articles to help you understand your options. And if you’re ready to hire an attorney, find one in your area who can help.
Search our directory by legal issue
Enter information in one or both fields (Required)
Answer a few questions and get helpful next steps for your legal issue.